心脏病专家和降脂饮食补充剂之间的复杂关系:恨还是爱?
Arrigo F G Cicero1, Alberto Corsini2
1Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Italy; Cardiovascular Medicine Unit, Heart, Chest and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Nutrition, metabolism, and cardiovascular diseases : NMCD
|January 15, 2026
概括
欧洲心脏病学会的指导方针可能会阻止营养药,但证据支持特定的降脂补充剂. 临床医生应优先考虑基于证据的选择,并改变心血管风险管理的生活方式.
科学领域:
- 心脏病学 心脏病学
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 最近欧洲心脏病学会 (ESC) 和欧洲动脉样硬化学会 (EAS) 的指导方针涉及降脂饮食补充剂.
- 一份声明不鼓励补充缺乏安全性和LDL胆固醇降低功效的补充剂,导致误解为全面禁止营养药.
研究的目的:
- 批判性地分析ESC/EAS指南更新关于降脂营养保健品.
- 澄清特定补充剂的证据基础及其在心血管疾病风险管理中的作用.
主要方法:
- 审查 ESC/EAS 2025 失脂症管理指南的更新.
- 对推类 (C类) 的分析及其影响.
- 影响因素的评估,如EFSA的意见和特定试验 (例如,SPORT试验).
- 对记录良好的营养保健品的证据评估未在更新中解决.
主要成果:
- 该指南关于补充剂的声明是基于专家意见 (C类),而不是强有力的证据.
- 误解是由于对红酵母大米和SPORT试验的担忧而引起的.
- 几种有效和安全的营养药 (植物固醇,柏柏林等) 被元分析支持,但被遗漏.
- 更新并没有取消基于证据的营养保健品.
结论:
- 临床医生应推基于证据的营养保健品,其安全性和有效性已得到证实.
- 营养药可以作为低风险个体的生活方式干预的辅助剂.
- 鼓励进一步的研究和对准则的细微解释,以获得最佳的患者护理.
相关概念视频
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Coronary Artery Disease IV: Preventive Measures
590
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Cardiomyopathy V: Interprofessional Care
339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Lipids: Dietary Sources and Requirements
1.8K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K


